Loading your page…
Each register with its number of medicines and a few of them.
Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.
CBG-MEB · 45 medicines
HALMED · 12 medicines
MS · 12 medicines · Historical list
AIFA · 9 medicines
ALIMS · 9 medicines
SFDA · 7 medicines · Historical list
HSA · 5 medicines
PHARMAC · 4 medicines
FDA · 4 medicines
Anvisa · 1 medicine · Historical list
EMA · 1 medicine · Historical list
Show all 1Every register, a page at a time. Strengths and packs are on each medicine’s page.
49 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Ropinirol Stada 2 MG Comprimidos de Liberacion Prolongada Efg | Spain | 2,280 mg | comprimido de liberación prolongada | Marketed | Laboratorio Stada S.L. |
| Ropinirol Stada 4 MG Comprimidos de Liberacion Prolongada Efg | Spain | 4,561 mg | comprimido de liberación prolongada | Marketed | Laboratorio Stada S.L. |
| Ropinirol Stada 8 MG Comprimidos de Liberacion Prolongada Efg | Spain | 9,121 mg | comprimido de liberación prolongada | Marketed | Laboratorio Stada S.L. |
| Ropinirol Krka 2 MG Comprimidos de Liberacion Prolongada Efg | Spain | 2,28 mg | comprimido de liberación prolongada | Marketed | Krka D.D. Novo Mesto |
| Ropinirol Krka 4 MG Comprimidos de Liberacion Prolongada Efg | Spain | 4,56 mg | comprimido de liberación prolongada | Marketed | Krka D.D. Novo Mesto |
| Ropinirol Krka 8 MG Comprimidos de Liberacion Prolongada Efg | Spain | 9,12 mg | comprimido de liberación prolongada | Marketed | Krka D.D. Novo Mesto |
| Ropinirol Teva 4 MG Comprimidos de Liberacion Prolongada Efg | Spain | 4,56 mg | comprimido de liberación prolongada | Marketed | Teva Pharma S.L.U. |
| Ropinirol Teva 8 MG Comprimidos de Liberacion Prolongada Efg | Spain | 9,12 mg | comprimido de liberación prolongada | Marketed | Teva Pharma S.L.U. |
| ROPINIROL PROLIB SANDOZ 2 mg COMPRIMIDOS DE LIBERACION PROLONGADA EFG | Spain | 2,28 mg | comprimido de liberación prolongada | Marketed | Sandoz Farmaceutica S.A. |
| ROPINIROL PROLIB SANDOZ 4 mg COMPRIMIDOS DE LIBERACION PROLONGADA EFG | Spain | 4,56 mg | comprimido de liberación prolongada | Marketed | Sandoz Farmaceutica S.A. |
| ROPINIROL PROLIB SANDOZ 8 mg COMPRIMIDOS DE LIBERACION PROLONGADA EFG | Spain | 9,12 mg | comprimido de liberación prolongada | Marketed | Sandoz Farmaceutica S.A. |
| Ropinirol Kern Pharma 2 MG Comprimidos de Liberacion Prolongada Efg | Spain | 2,28 mg | comprimido de liberación prolongada | Marketed | Kern Pharma S.L. |
| Ropinirol Kern Pharma 4 MG Comprimidos de Liberacion Prolongada Efg | Spain | 4,56 mg | comprimido de liberación prolongada | Marketed | Kern Pharma S.L. |
| Ropinirol Kern Pharma 8 MG Comprimidos de Liberacion Prolongada Efg | Spain | 9,12 mg | comprimido de liberación prolongada | Marketed | Kern Pharma S.L. |
| Ropinirol Cinfa 2 MG Comprimidos de Liberación Prolongada Efg | Spain | 2,28 mg | comprimido de liberación prolongada | Authorised | Laboratorios Cinfa S.A. |
| Ropinirol Cinfa 3 MG Comprimidos de Liberación Prolongada Efg | Spain | 3,42 mg | comprimido de liberación prolongada | Authorised | Laboratorios Cinfa S.A. |
| Ropinirol Cinfa 4 MG Comprimidos de Liberación Prolongada Efg | Spain | 4,56 mg | comprimido de liberación prolongada | Authorised | Laboratorios Cinfa S.A. |
| Ropinirol Cinfa 8 MG Comprimidos de Liberación Prolongada Efg | Spain | 9,121 mg | comprimido de liberación prolongada | Authorised | Laboratorios Cinfa S.A. |
| ROLPRYNA SR 2 mg COMPRIMIDOS DE LIBERACION PROLONGADA EFG | Spain | 2,28 mg | comprimido de liberación prolongada | Marketed | Krka D.D. Novo Mesto |
| ROLPRYNA SR 4 mg COMPRIMIDOS DE LIBERACION PROLONGADA EFG | Spain | 4,56 mg | comprimido de liberación prolongada | Marketed | Krka D.D. Novo Mesto |
| ROLPRYNA SR 8 mg COMPRIMIDOS DE LIBERACION PROLONGADA EFG | Spain | 9,12 mg | comprimido de liberación prolongada | Marketed | Krka D.D. Novo Mesto |
| REQUIP-PROLIB 2 mg, COMPRIMIDOS DE LIBERACION PROLONGADA | Spain | 2 mg | comprimido de liberación prolongada | Marketed | Glaxosmithkline S.A. |
| REQUIP-PROLIB 4 mg, COMPRIMIDOS DE LIBERACION PROLONGADA | Spain | 4 mg | comprimido de liberación prolongada | Marketed | Glaxosmithkline S.A. |
| REQUIP-PROLIB 8 mg, COMPRIMIDOS DE LIBERACION PROLONGADA | Spain | 8 mg | comprimido de liberación prolongada | Marketed | Glaxosmithkline S.A. |
| REQUIP 1 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | Spain | 1 mg | comprimido recubierto con película | Marketed | Glaxosmithkline S.A. |
The same brand on several registers.
The companies holding its medicines, the most first.
How the registers write it, in their own languages.
Compiled by Prognia from the public medicine registers of AEMPS, AIFA, ALIMS, Anvisa, CBG-MEB, EMA, FDA, HALMED, Health Canada, HSA, MS, PHARMAC and SFDA. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
